SK pharmteco Published in BioProcess International: Elevating the CGT Manufacturing Game: How Outsourcing Enables Success
SK pharmteco was recently featured in “BioProcess International” in their article titled “Elevating the CGT Manufacturing Game: How Outsourcing Enables...
SK pharmteco Published in Pharma’s Almanac: What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
SK pharmteco recently participated in a roundtable discussion with “Pharma’s Almanac” titled “What are the Current Investment Trends in the...
SK pharmteco Published in Pharma’s Almanac: How Can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?
SK pharmteco recently participated in a roundtable discussion with “Pharma’s Almanac” titled “How Can Life Science Technology Providers Support the...
John Lee, Global Head of CGT Published in Cytotherapy – CGT Development: Selecting the Right CDMO
Cell and Gene Therapy Development: Selecting the Right Contract Development and Manufacturing Organization In recent years, the number of cell...
How CDMOs Have Become Emerging Technology Influencers
The science behind advanced, cell-and-gene-based drugs is developing rapidly, opening new opportunities for targeted, highly effective therapeutics.
Cell Therapy Manufacturing: Build or Buy?
Allogeneic cell therapy is poised to be paradigm-shifting treatment from a scale, cost, and reach perspective. In this white paper, we discuss the considerations for…
